ES8304094A1 - Procedimiento para preparar una sal de pirimidona. - Google Patents

Procedimiento para preparar una sal de pirimidona.

Info

Publication number
ES8304094A1
ES8304094A1 ES512629A ES512629A ES8304094A1 ES 8304094 A1 ES8304094 A1 ES 8304094A1 ES 512629 A ES512629 A ES 512629A ES 512629 A ES512629 A ES 512629A ES 8304094 A1 ES8304094 A1 ES 8304094A1
Authority
ES
Spain
Prior art keywords
salt
pyrimidone
preparation
olylmetiltio
methanosulphonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512629A
Other languages
English (en)
Other versions
ES512629A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES8304094A1 publication Critical patent/ES8304094A1/es
Publication of ES512629A0 publication Critical patent/ES512629A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Air-Conditioning For Vehicles (AREA)

Abstract

_(PROCEDIMIENTO PARA PREPARAR UNA SAL DE PIRIMIDONA . CONSISTE EN HACER REACCIONAR LA 2-2-(5-METIL-4-IMIDAZ-OLILMETILTIO) ETILAMINO-5-(1,3-BENZODIOXOLIL)-METIL-4-PRIMIDONA CON METANOFULFONICO; LA REACCION TIENE LUGAR EN SOLUCION ACUOSA NORMALMENTE A TEMPERATURA ELEVADA, POR ENCIMA DE 50 C. LA SAL DI (METANOSULFONATO) PUEDE AISLARSE Y PURIFICARSE POR METODOS CONOCIDOS. ACTIVIDAD ANTAGONISTA DE RECEPTORES DE HISTAMINA H2.
ES512629A 1981-05-30 1982-05-28 Procedimiento para preparar una sal de pirimidona. Granted ES512629A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8116615 1981-05-30

Publications (2)

Publication Number Publication Date
ES8304094A1 true ES8304094A1 (es) 1983-02-16
ES512629A0 ES512629A0 (es) 1983-02-16

Family

ID=10522169

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512629A Granted ES512629A0 (es) 1981-05-30 1982-05-28 Procedimiento para preparar una sal de pirimidona.

Country Status (12)

Country Link
US (1) US4450161A (es)
EP (1) EP0067579B1 (es)
JP (1) JPS57206683A (es)
AT (1) ATE9345T1 (es)
AU (1) AU8431082A (es)
DE (1) DE3260719D1 (es)
DK (1) DK230482A (es)
ES (1) ES512629A0 (es)
GB (1) GB2112380A (es)
GR (1) GR76450B (es)
PT (1) PT74958B (es)
ZA (1) ZA823766B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones

Also Published As

Publication number Publication date
PT74958B (en) 1983-12-23
PT74958A (en) 1982-06-01
ZA823766B (en) 1983-04-27
EP0067579A1 (en) 1982-12-22
JPS57206683A (en) 1982-12-18
AU8431082A (en) 1982-12-09
GB2112380A (en) 1983-07-20
US4450161A (en) 1984-05-22
GR76450B (es) 1984-08-10
ATE9345T1 (de) 1984-09-15
DK230482A (da) 1982-12-01
ES512629A0 (es) 1983-02-16
EP0067579B1 (en) 1984-09-12
DE3260719D1 (en) 1984-10-18

Similar Documents

Publication Publication Date Title
AR240830A1 (es) Procedimiento para preparar derivados de acidos naftiridin quinolin-y benzoxazincarboxilicos.
IT8520869A0 (it) Procedimento di fermentazione per produrre acido ialuronico.
ES519845A0 (es) Procedimiento para preparar derivados de amidas.
AR240876A2 (es) Un procedimiento para la preparacion de un catalizador que contiene plata y dicho catalizador
UA7088A1 (uk) Спосіб одержання солі 2-(2-гідроксіетоксі)етіламіна та 3,6-діхлор-2-метоксібензойної кислоти
ES8603480A1 (es) Procedimiento para preparar nuevos imidazoles
ES509039A0 (es) Procedimiento de obtencion de polieteres de utilidad como espesantes para sistemas acuosos.
EP0148094A3 (en) Anti-tumor agent comprising an o-benzylidene-l-ascorbic acid or a salt thereof, and the production of the latter compound
IT7868768A0 (it) Soluzione catalitica per la deposizione anelettrica di metalli
ES556599A0 (es) Procedimiento para evitar la formacion de espuma en sistemas acuosas.
DK426185D0 (da) Nucleosid- og purinderivater
IT8025515A0 (it) Procedimento per ottimizzare il consumo di carburante.
GB2099008B (en) Enzymatic process for the treatment of xanthan gums to improve the filtrability of their aqueous solutions
IT7927749A0 (it) Procedimento per la preparazione di urea.
IT8223775A0 (it) Processo per la sintesi di urea.
DE3278505D1 (en) Hybridoma antibody which inhibits interleukin-2 activity and its use as a reagent for interleukin-2 detection, the production of said antibody, a process for producing hybrid anti-interleukin-2 antibody producing cells, and such cells
DE3581731D1 (de) Waessrige systeme, die aminosulfonsaeurederivate von carbonsaeuren enthalten.
ES8304094A1 (es) Procedimiento para preparar una sal de pirimidona.
IT7830668A0 (it) Processo per la preparazione disoluzioni acquose fortemente alcaline di tensioattivi non ionici.
ES2022858B3 (es) Anodo y celula electroquimica para la recuperacion de metales de disoluciones acuosas.
IT7828098A0 (it) Processo per la preparazione di granulati dotati di attivita'biologica.
ES546136A0 (es) Proceso para producir derivados de 1,4-dihidro-piridina-3,5,dicarboxilato.
IT1106279B (it) Procedimento per depurare soluzioni acquose di alogenuri alcalini per l'elettrolisi
DE3263581D1 (en) Recovery of molybdenum as an aqueous solution
ES516299A0 (es) "procedimiento para preparar nuevos derivados de 20,21-dinoreburnamenina".